Literature DB >> 8167118

Cytomegalovirus infection amplifies class I major histocompatibility complex expression on cultured human endothelial cells.

R M Tuder1, A Weinberg, N Panajotopoulos, J Kalil.   

Abstract

Cytomegalovirus infection, a common complication in immunosuppressed graft recipients, bears an adverse impact on graft survival. Cytomegalovirus enhances the expression of the monotypic determinants of the class I major histocompatibility complex molecule by the endothelium, possibly rendering the endothelial cells more immunogenic and prone to attack by the allogeneic lymphocytes. In the present study, we focused on the effect of cytomegalovirus on the endothelial cell expression of different class I genes, on the relation between the extent of endothelial cell infection and the class I effect, and on the time course of the class I changes induced by the cytomegalovirus infection. Cytomegalovirus infection of primary cultures of human umbilical vein endothelial cells augmented the expression of the A2, A3, and B7 class I major histocompatibility complex genes when compared with uninfected cells. beta 2 microglobulin upregulation by the infected cells paralleled the changes in specific class I expression; this effect was significant only after 7 days after infection. Double immunocytochemical staining and fluorescence-activated cell sorter analysis revealed that the class I enhancement was uniform throughout the umbilical vein endothelial cell monolayer and not restricted to the cells that expressed cytomegalovirus early or late antigens. Ultraviolet-inactivated supernatants from infected umbilical vein endothelial cell did not increase class I expression on uninfected cells. In conclusion, cytomegalovirus might affect graft survival by amplifying the changes in class I expression beyond the sites of viral replication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8167118

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  3 in total

1.  Outcomes among pediatric heart transplant recipients.

Authors:  R J Gajarski; H M Rosenblatt; S W Denfield; K O Schowengerdt; J K Price; J A Towbin
Journal:  Tex Heart Inst J       Date:  1997

2.  Early renal function trajectories, cytomegalovirus serostatus and long-term graft outcomes in kidney transplant recipients.

Authors:  Jonathan P Law; Richard Borrows; David McNulty; Adnan Sharif; Charles J Ferro
Journal:  BMC Nephrol       Date:  2021-03-20       Impact factor: 2.388

3.  Behaviour of non-donor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantation.

Authors:  Nithya S Krishnan; Daniel Zehnder; Sunil Daga; Dave Lowe; F T Lam; Habib Kashi; Lam Chin Tan; Christopher Imray; Rizwan Hamer; David Briggs; Neil Raymond; Robert M Higgins
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.